Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready
Inflammatix Inc. has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 6 distinct examiners and 5 distinct art units. This high ratio of examiners and art units to office actions suggests that the company's biotechnology filings are technically diverse and being reviewed across many different office divisions. The involvement of 5 distinct art units indicates that the portfolio covers a broad range of specialized pharmaceutical or biological subject matter.
SODERQUIST, ARLEN is the busiest examiner, though they are only responsible for 1 pending office action. Because each of the 6 pending actions is handled by a different distinct examiner, the company must manage 6 unique examination styles simultaneously. This lack of examiner concentration requires a highly adaptable prosecution strategy. Practitioners must be prepared to navigate the specific standards of 5 different art units to ensure consistent results across the Biotechnology & Pharmaceuticals portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (83%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SODERQUIST, ARLEN | 1 | 59.7% | +26.3% |
| BAILEY, STEVEN WILLIAM | 1 | 31.6% | +15.2% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
| HORLICK, KENNETH R | 1 | 78.9% | +15.3% |
| KALLAL, ROBERT JAMES | 1 | 60.0% | +32.4% |
| WOITACH, JOSEPH T | 1 | 49.9% | +28.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18387311 | SYSTEMS AND METHODS FOR DERIVING AND OPTIMIZING CLASSIFIERS FROM MULTIPLE DATASETS | BAILEY, STEVEN WILLIAM | 125d overdue |
| 18493324 | FLUIDIC DEVICE AND METHODS FOR CHARACTERIZATION OF AN INFECTION OR OTHER CONDITION | HORLICK, KENNETH R | 99d overdue |
| 18664790 | FLUIDIC METHODS | SODERQUIST, ARLEN | — |
| 18557784 | METHODS OF DIAGNOSIS OF RESPIRATORY VIRAL INFECTIONS | JONES, CHRISTINE MICHELLE | — |
| 17736495 | SYSTEMS AND METHODS FOR ASSESSING A BACTERIAL OR VIRAL STATUS OF A SAMPLE | KALLAL, ROBERT JAMES | — |
| 17274140 | ASSESSING HOST RNA USING ISOTHERMAL AMPLIFICATION AND RELATIVE ABUNDANCE | WOITACH, JOSEPH T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18387311 | SYSTEMS AND METHODS FOR DERIVING AND OPTIMIZING CLASSIFIERS FROM MULTIPLE DATASETS | BAILEY, STEVEN WILLIAM | 125d overdue |
| 18493324 | FLUIDIC DEVICE AND METHODS FOR CHARACTERIZATION OF AN INFECTION OR OTHER CONDITION | HORLICK, KENNETH R | 99d overdue |
| 18664790 | FLUIDIC METHODS | SODERQUIST, ARLEN | — |
| 17736495 | SYSTEMS AND METHODS FOR ASSESSING A BACTERIAL OR VIRAL STATUS OF A SAMPLE | KALLAL, ROBERT JAMES | — |
| 17274140 | ASSESSING HOST RNA USING ISOTHERMAL AMPLIFICATION AND RELATIVE ABUNDANCE | WOITACH, JOSEPH T | — |
| Art Unit | Apps |
|---|---|
| 1687 | 2 |
| 1797 | 1 |
| 1682 | 1 |
| 1681 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18664790 | FLUIDIC METHODS | SODERQUIST, ARLEN | 1797 | §102§112 | Non-Final OA | — | Pending | May 15, 2024 |
| 18387311 | SYSTEMS AND METHODS FOR DERIVING AND OPTIMIZING CLASSIFIERS FROM MULTIPLE DATASETS | BAILEY, STEVEN WILLIAM | 1687 | §101§103 | Final Rejection | 125d overdue | Pending | Nov 06, 2023 |
| 18557784 | METHODS OF DIAGNOSIS OF RESPIRATORY VIRAL INFECTIONS | JONES, CHRISTINE MICHELLE | 1682 | §101§103§112DP | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18493324 | FLUIDIC DEVICE AND METHODS FOR CHARACTERIZATION OF AN INFECTION OR OTHER CONDITION | HORLICK, KENNETH R | 1681 | §101§103 | Final Rejection | 99d overdue | Pending | Oct 24, 2023 |
| 17736495 | SYSTEMS AND METHODS FOR ASSESSING A BACTERIAL OR VIRAL STATUS OF A SAMPLE | KALLAL, ROBERT JAMES | 1685 | §101§102§103§112 | Non-Final OA | — | Pending | May 04, 2022 |
| 17274140 | ASSESSING HOST RNA USING ISOTHERMAL AMPLIFICATION AND RELATIVE ABUNDANCE | WOITACH, JOSEPH T | 1687 | §101§112 | Final Rejection | — | Pending | Mar 05, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial